Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate
- Author
- BRAVE, Michael1 ; GOODMAN, Vicki1 ; MEN, Angela3 ; NOORY, Carol3 ; RAMCHANDANI, Roshni3 ; KENNA, Leslie3 ; BOOTH, Brian3 ; GOBBURU, Joga3 ; XIAOPING JIANG4 ; SRIDHARA, Rajeshwari4 ; JUSTICE, Robert1 ; PAZDUR, Richard1 ; KAMINSKAS, Edvardas1 ; FARRELL, Ann1 ; TIMMER, William2 ; POPE, Sarah2 ; HARAPANHALLI, Ravi2 ; SABER, Haleh1 ; MORSE, David1 ; BULLOCK, Julie3
[1] office of Oncology Drug Products, Office of New Drugs, United States
[2] Office of New Drug Quality Assessment, Office of Pharmaceutical Science, United States
[3] Office of Clinical Pharmacology, Office of Translational Sciences, United States
[4] Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, United States - Source
Clinical cancer research. 2008, Vol 14, Num 2, pp 352-359, 8 p ; ref : 32 ref
- ISSN
- 1078-0432
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Chromosome C9 anormal Chromosome G22 anormal Chromosome Ph1 Imatinib Leucémie aiguë lymphoblastique Leucémie myéloïde chronique Résistance STI 571 Aberration chromosomique Cancer Chromosome anormal Enzyme Hémopathie maligne Inhibiteur de la tyrosine kinase Inhibiteur enzyme Protein-tyrosine kinase Syndrome lymphoprolifératif Syndrome myéloprolifératif Transferases
- Keyword (en)
- Antineoplastic agent Abnormal chromosome C9 Abnormal chromosome G22 Philadelphia chromosome Imatinib Acute lymphocytic leukemia Chronic myelogenous leukemia Resistance Chromosomal aberration Cancer Abnormal chromosome Enzyme Malignant hemopathy Tyrosine kinase inhibitor Enzyme inhibitor Protein-tyrosine kinase Lymphoproliferative syndrome Myeloproliferative syndrome Transferases
- Keyword (es)
- Anticanceroso Cromosoma C9 anormal Cromosoma G22 anormal Cromosoma Ph1 Imatinib Leucemia aguda linfoblástica Leucemia mieloidea crónica Resistencia Aberración cromosómica Cáncer Cromosoma anormal Enzima Hemopatía maligna Inhibidor tyrosine kinase Inhibidor enzima Protein-tyrosine kinase Linfoproliferativo síndrome Mieloproliferativo síndrome Transferases
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20144819
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1158/1078-0432.CCR-07-4175 
https://dx.doi.org/10.1158/1078-0432.CCR-07-4175
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4175\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"352\";s:8:\"\u0000*\u0000epage\";s:3:\"359\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BRAVE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"GOODMAN, Vicki\";i:1;s:11:\"MEN, Angela\";i:2;s:12:\"NOORY, Carol\";i:3;s:19:\"RAMCHANDANI, Roshni\";i:4;s:13:\"KENNA, Leslie\";i:5;s:12:\"BOOTH, Brian\";i:6;s:13:\"GOBBURU, Joga\";i:7;s:14:\"XIAOPING JIANG\";i:8;s:20:\"SRIDHARA, Rajeshwari\";i:9;s:15:\"JUSTICE, Robert\";i:10;s:15:\"PAZDUR, Richard\";i:11;s:19:\"KAMINSKAS, Edvardas\";i:12;s:12:\"FARRELL, Ann\";i:13;s:15:\"TIMMER, William\";i:14;s:11:\"POPE, Sarah\";i:15;s:18:\"HARAPANHALLI, Ravi\";i:16;s:12:\"SABER, Haleh\";i:17;s:12:\"MORSE, David\";i:18;s:14:\"BULLOCK, Julie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4175\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"352\";s:8:\"\u0000*\u0000epage\";s:3:\"359\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BRAVE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"GOODMAN, Vicki\";i:1;s:11:\"MEN, Angela\";i:2;s:12:\"NOORY, Carol\";i:3;s:19:\"RAMCHANDANI, Roshni\";i:4;s:13:\"KENNA, Leslie\";i:5;s:12:\"BOOTH, Brian\";i:6;s:13:\"GOBBURU, Joga\";i:7;s:14:\"XIAOPING JIANG\";i:8;s:20:\"SRIDHARA, Rajeshwari\";i:9;s:15:\"JUSTICE, Robert\";i:10;s:15:\"PAZDUR, Richard\";i:11;s:19:\"KAMINSKAS, Edvardas\";i:12;s:12:\"FARRELL, Ann\";i:13;s:15:\"TIMMER, William\";i:14;s:11:\"POPE, Sarah\";i:15;s:18:\"HARAPANHALLI, Ravi\";i:16;s:12:\"SABER, Haleh\";i:17;s:12:\"MORSE, David\";i:18;s:14:\"BULLOCK, Julie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4175\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4175\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"352\";s:8:\"\u0000*\u0000epage\";s:3:\"359\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BRAVE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"GOODMAN, Vicki\";i:1;s:11:\"MEN, Angela\";i:2;s:12:\"NOORY, Carol\";i:3;s:19:\"RAMCHANDANI, Roshni\";i:4;s:13:\"KENNA, Leslie\";i:5;s:12:\"BOOTH, Brian\";i:6;s:13:\"GOBBURU, Joga\";i:7;s:14:\"XIAOPING JIANG\";i:8;s:20:\"SRIDHARA, Rajeshwari\";i:9;s:15:\"JUSTICE, Robert\";i:10;s:15:\"PAZDUR, Richard\";i:11;s:19:\"KAMINSKAS, Edvardas\";i:12;s:12:\"FARRELL, Ann\";i:13;s:15:\"TIMMER, William\";i:14;s:11:\"POPE, Sarah\";i:15;s:18:\"HARAPANHALLI, Ravi\";i:16;s:12:\"SABER, Haleh\";i:17;s:12:\"MORSE, David\";i:18;s:14:\"BULLOCK, Julie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4175\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"352\";s:8:\"\u0000*\u0000epage\";s:3:\"359\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BRAVE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"GOODMAN, Vicki\";i:1;s:11:\"MEN, Angela\";i:2;s:12:\"NOORY, Carol\";i:3;s:19:\"RAMCHANDANI, Roshni\";i:4;s:13:\"KENNA, Leslie\";i:5;s:12:\"BOOTH, Brian\";i:6;s:13:\"GOBBURU, Joga\";i:7;s:14:\"XIAOPING JIANG\";i:8;s:20:\"SRIDHARA, Rajeshwari\";i:9;s:15:\"JUSTICE, Robert\";i:10;s:15:\"PAZDUR, Richard\";i:11;s:19:\"KAMINSKAS, Edvardas\";i:12;s:12:\"FARRELL, Ann\";i:13;s:15:\"TIMMER, William\";i:14;s:11:\"POPE, Sarah\";i:15;s:18:\"HARAPANHALLI, Ravi\";i:16;s:12:\"SABER, Haleh\";i:17;s:12:\"MORSE, David\";i:18;s:14:\"BULLOCK, Julie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4175\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"352\";s:8:\"\u0000*\u0000epage\";s:3:\"359\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BRAVE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"GOODMAN, Vicki\";i:1;s:11:\"MEN, Angela\";i:2;s:12:\"NOORY, Carol\";i:3;s:19:\"RAMCHANDANI, Roshni\";i:4;s:13:\"KENNA, Leslie\";i:5;s:12:\"BOOTH, Brian\";i:6;s:13:\"GOBBURU, Joga\";i:7;s:14:\"XIAOPING JIANG\";i:8;s:20:\"SRIDHARA, Rajeshwari\";i:9;s:15:\"JUSTICE, Robert\";i:10;s:15:\"PAZDUR, Richard\";i:11;s:19:\"KAMINSKAS, Edvardas\";i:12;s:12:\"FARRELL, Ann\";i:13;s:15:\"TIMMER, William\";i:14;s:11:\"POPE, Sarah\";i:15;s:18:\"HARAPANHALLI, Ravi\";i:16;s:12:\"SABER, Haleh\";i:17;s:12:\"MORSE, David\";i:18;s:14:\"BULLOCK, Julie\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
